Nimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic Cancer
Clinical trial NCT06409429 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06409429
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2027-05-30
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.